Skip to main content
. 2017 Jul 6;10:250. doi: 10.1186/s13104-017-2568-y

Table 1.

Demographic data, disease characteristics and patients experience with follow-up. Relapsing remitting MS (RR MS), secondary progressive MS (SP MS), primary progressive MS (PP MS)

Demographics
Age (n = 159) (years) [mean (SD)] 54 (11.5)
Sex (n = 158) M/F [N (%)] 39/119 (25/75)
Education, years after primary school (n = 156) <3/3–6/>6 [N (%)] 62/62/32 (39/39/20)
Employment status (n = 153)
Full time/part time/disabled or retired [N (%)] 29/20/104 (19/13/68)
Marital status (n = 155)
Single or widowed/married or cohabitant [N (%)] 30/125 (20/80)
Disease characteristics
Type of MS (n = 159)
RR/SP/PP/Unknown [N (%)] 71/22/17/49 (45/14/11/31)
Duration of MS (n = 157) (years) [mean (SD)] 12 (9.1)
Walking distance without support (n = 153)
Unlimited/>100 m/<100 m [N (%)] 66/35/52 (41/22/33)
Use of mobility aids in daily life (n = 148)
None/walker, cane or other/wheelchair [N (%)] 84/28/36 (53/18/23)
MS treatment now (n = 156)
None/Interferones or glatirameracetate/natalizumab/fingolimod [N (%)] 104/35/14/6 (65/22/9/4)